GLOBUS MEDICAL INC
Close on Oct 19, 2026
- Market cap
- $10.39B
- P/E (TTM)
- 19.3
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | During market hours | $789.60M | $1.10 | $1.34 |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | During market hours | $759.90M | $0.90 | $1.12 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 24, 2026 | During market hours | $826.40M | $1.03 | $1.28 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | During market hours | $769.00M | $0.88 | $1.18 |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 21, 2025 | Before market open | $745.30M | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | During market hours | $598.10M | $0.54 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 20, 2025 | During market hours | $657.30M | $0.19 | $0.84 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 5, 2024 | During market hours | – | $0.38 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | During market hours | $629.70M | $0.23 | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | During market hours | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 20, 2024 | During market hours | – | – | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| non-GAAP fully diluted EPSnon-GAAP | full-year 2026 | $4.95 to $5.05 | Raised |
| revenue | full-year 2026 | $3.18B to $3.22B | Maintained |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Globus Medical filed with the SEC
Globus Medical Reports Second Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports First Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Announces Board Departure
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Globus Medical Reports Fourth Quarter and Full Year 2025 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Third Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Second Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Globus Medical Announce s $500 M illion Share Repurchase Program
Other events · EX-99.1 to Form 8-K
Globus Medical Reports First Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical completes acquisition of Nevro Corp.
Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
Globus Medical Reports Fourth Quarter and Full Year 2024 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical to Acquire Nevro Corp.
Material agreement · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Third Quarter 202 4 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Second Quarter 202 4 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports First Quarter 202 4 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Fourth Quarter and Full Year 20 2 3 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Third Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Completes Merger with NuVasive
Material agreement · Acquisition or disposition completed · New financial obligation · Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Globus Medical Reports Second Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports First Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive
Shareholder vote results · Other events · EX-99.1 to Form 8-K
Globus Medical Reports Fourth Quarter and Full Year 20 2 2 Results
Results of operations · EX-99.1 to Form 8-K
Combining to create an innovative
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Globus Medical and NuVasive to Combine in All-Stock Transaction to
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Globus Medical Reports Third Quarter 20 2 2 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Second Quarter 20 2 2 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports First Quarter 20 2 2 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Globus Medical Announces the Expansion of its Share Repurchase Program
Other events · EX-99.1 to Form 8-K
Globus Medical Reports Fourth Quarter and Full Year 20 2 1 Results
Results of operations · EX-99.1 to Form 8-K
Globus Medical Reports Third Quarter 2021 Results
Results of operations · EX-99.1 to Form 8-K